Search

Filter by Topic

Displaying 1 - 3 of 3 items.

Leonard Colebrook’s Use of Sulfonamides as a Treatment for Puerperal Fever (1935–1937)

Between 1935 and 1937, Leonard Colebrook showed that sulfonamides, a class of antibacterial drugs, worked as an effective treatment for puerperal fever. Puerperal fever is a bacterial infection that can occur in the uterus of women after giving birth. At the time of Colebrook’s study, puerperal fever remained a common disease due to both the lack of hygienic practices in hospitals and a treatment for the disease. After successfully using Prontosil, a sulfanilamide, to cure a patient who was going to die from puerperal fever, Colebrook began experiments with the drug.

Format: Articles

Subject: Experiments

The First Successful Cloning of a Gaur (2000), by Advanced Cell Technology

Advanced Cell Technology (ACT), a stem cell biotechnology company in Worcester, Massachusetts, showed the potential for cloning to contribute to conservation efforts. In 2000 ACT researchers in the United States cloned a gaur (Bos gaurus), an Asian ox with a then declining wild population. The researchers used cryopreserved gaur skin cells combined with an embryo of a domestic cow (Bos taurus). A domestic cow also served as the surrogate for the developing gaur clone.

Format: Articles

Subject: Experiments

Sonja Vernes, et al.'s Experiments On the Gene Networks Affected by the Foxp2 Protein (2011)

In 2011, Sonja Vernes and Simon Fisher performed a series of experiments to determine which developmental processes are controlled by the mouse protein Foxp2. Previous research showed that altering the Foxp2 protein changed how neurons grew, so Vernes and Fisher hypothesized that Foxp2 would affect gene networks that involved in the development of neurons, or nerve cells. Their results confirmed that Foxp2 affected the development of gene networks involved in the growth of neurons, as well as networks that are involved in cell specialization and cell communication.

Format: Articles

Subject: Experiments